Digital Library
Close Browse articles from a journal
 
Search for with title:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             72 results found
no title author magazine year volume issue page(s) type
1 Canadian Implantable Defibrillator Study (CIDS): Perspective of the Principal Investigators S.J. Connolly
 1998
 2 1 p. 11-12
2 p.
 article
2 Canadian Implantable Defibrillator Study (CIDS): Perspective of the Principal Investigators Connolly, S.J.
 1998
 2 1 p. 11-12
 article
3 Clinical Cardiac Electrophysiology in Australia David L. Ross
 1998
 2 1 p. 73-74
2 p.
 article
4 Clinical Cardiac Electrophysiology in Australia Ross, David L.
 1998
 2 1 p. 73-74
 article
5 Clinical Implications of ATRAMI: A Clinicians Perspective Raul D. Mitrani
 1998
 2 1 p. 41-43
3 p.
 article
6 Clinical Implications of ATRAMI: A Clinician's Perspective Mitrani, Raul D.
 1998
 2 1 p. 41-43
 article
7 Clinical Implications of MADIT, AVID, CIDS, CABG Patch Trial and CASH: A North American Perspective Jeremy N. Ruskin
 1998
 2 1 p. 17-20
4 p.
 article
8 Clinical Implications of MADIT, AVID, CIDS, CABG Patch Trial and CASH: A North American Perspective Ruskin, Jeremy N.
 1998
 2 1 p. 17-20
 article
9 Clinical Implications of MADIT, AVID, CIDS, the CABG Patch Trial and CASH: A European Perspective M.M. Gallagher
 1998
 2 1 p. 21-22
2 p.
 article
10 Clinical Implications of MADIT, AVID, CIDS, the CABG Patch Trial and CASH: A European Perspective Gallagher, M.M.
 1998
 2 1 p. 21-22
 article
11 Clinical Implications of the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial: The Investigators Perspective H. Leon Green
 1998
 2 1 p. 8-10
3 p.
 article
12 Clinical Implications of the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial: The Investigators' Perspective Green, H. Leon
 1998
 2 1 p. 8-10
 article
13 Clinical Implications of the CABG Patch Trial: An Investigators Perspective John P. DiMarco
 1998
 2 1 p. 13-15
3 p.
 article
14 Clinical Implications of the CABG Patch Trial: An Investigator's Perspective DiMarco, John P.
 1998
 2 1 p. 13-15
 article
15 Clinical Implications of the CAMIAT, EMIAT and SWORD Trials: A European Perspective Martin Borggrefe
 1998
 2 1 p. 34-35
2 p.
 article
16 Clinical Implications of the CAMIAT, EMIAT and SWORD Trials: A European Perspective Borggrefe, Martin
 1998
 2 1 p. 34-35
 article
17 Clinical Implications of the CAMIAT, EMIAT and SWORD Trials: A North American Perspective Jeffrey L. Anderson
 1998
 2 1 p. 30-33
4 p.
 article
18 Clinical Implications of the CAMIAT, EMIAT and SWORD Trials: A North American Perspective Anderson, Jeffrey L.
 1998
 2 1 p. 30-33
 article
19 Clinical Implications of the CAMIAT, EMIAT and SWORD Trials: A South American Perspective Hernán C. Doval
 1998
 2 1 p. 36-37
2 p.
 article
20 Clinical Implications of the CAMIAT, EMIAT and SWORD Trials: A South American Perspective Doval, Hernán C.
 1998
 2 1 p. 36-37
 article
21 Clinical Implications of the Canadian Amiodarone Myocardial Infarction Arrhythmia Trial (CAMIAT) John A. Cairns
 1998
 2 1 p. 23-25
3 p.
 article
22 Clinical Implications of the Canadian Amiodarone Myocardial Infarction Arrhythmia Trial (CAMIAT) Cairns, John A.
 1998
 2 1 p. 23-25
 article
23 Clinical Implications of the European Myocardial Infarct Amiodarone Trial (EMIAT) A. John Camm
 1998
 2 1 p. 26-27
2 p.
 article
24 Clinical Implications of the European Myocardial Infarct Amiodarone Trial (EMIAT) Camm, A. John
 1998
 2 1 p. 26-27
 article
25 Clinical Implications of the Multicenter Automatic Defibrillator Implantation Trial (MADIT): An Investigators Perspective Arthur J. Moss
 1998
 2 1 p. 6-7
2 p.
 article
26 Clinical Implications of the Multicenter Automatic Defibrillator Implantation Trial (MADIT): An Investigator's Perspective Moss, Arthur J.
 1998
 2 1 p. 6-7
 article
27 Clinical Implications of the North American Vasovagal Pacemaker Study David G. Benditt
 1998
 2 1 p. 54-56
3 p.
 article
28 Clinical Implications of the North American Vasovagal Pacemaker Study Benditt, David G.
 1998
 2 1 p. 54-56
 article
29 Clinical Implications of the Stroke Prevention in Atrial Fibrillation III Trial: A Clinicians Perspective Gregory Y.H. Lip
 1998
 2 1 p. 49-51
3 p.
 article
30 Clinical Implications of the Stroke Prevention in Atrial Fibrillation III Trial: A Clinician's Perspective Lip, Gregory Y.H.
 1998
 2 1 p. 49-51
 article
31 Clinical Implications of the Survival with Oral D-Sotalol (SWORD) Trial: An Investigation of Patients with Left Ventricular Dysfunction after Myocardial Infarction Craig M. Pratt
 1998
 2 1 p. 28-29
2 p.
 article
32 Clinical Implications of the Survival with Oral D-Sotalol (SWORD) Trial: An Investigation of Patients with Left Ventricular Dysfunction after Myocardial Infarction Pratt, Craig M.
 1998
 2 1 p. 28-29
 article
33 Conversion of Atrial Fibrillation: Pills, Shots, or Shocks? Philip J. Podrid
 1998
 2 1 p. 64-68
5 p.
 article
34 Conversion of Atrial Fibrillation: Pills, Shots, or Shocks? Podrid, Philip J.
 1998
 2 1 p. 64-68
 article
35 Electrophysiology Practice in a Health Maintenance Organization Simón Milstein
 1998
 2 1 p. 89-90
2 p.
 article
36 Electrophysiology Practice in a Health Maintenance Organization Milstein, Simón
 1998
 2 1 p. 89-90
 article
37 EP Practice Patterns, Reimbursement and Health Care Policy in Canada D. George Wyse
 1998
 2 1 p. 83-85
3 p.
 article
38 EP Practice Patterns, Reimbursement and Health Care Policy in Canada Wyse, D. George
 1998
 2 1 p. 83-85
 article
39 EP Practice Patterns, Reimbursement and Health Care Policy in France Pierre Maison-Blanche
 1998
 2 1 p. 80-80
1 p.
 article
40 EP Practice Patterns, Reimbursement and Health Care Policy in France Maison-Blanche, Pierre
 1998
 2 1 p. 80
 article
41 EP Practice Patterns, Reimbursement and Health Care Policy in Israel Michael Glikson
 1998
 2 1 p. 77-79
3 p.
 article
42 EP Practice Patterns, Reimbursement and Health Care Policy in Israel Glikson, Michael
 1998
 2 1 p. 77-79
 article
43 EP Practice Patterns, Reimbursement and Health Care Policy in South Korea You-Ho Kim
 1998
 2 1 p. 71-72
2 p.
 article
44 EP Practice Patterns, Reimbursement and Health Care Policy in South Korea Kim, You-Ho
 1998
 2 1 p. 71-72
 article
45 Evolving Indications for Permanent Pacing in Patients with Vasovagal Syncope Robert S. Sheldon
 1998
 2 1 p. 52-53
2 p.
 article
46 Evolving Indications for Permanent Pacing in Patients with Vasovagal Syncope Sheldon, Robert S.
 1998
 2 1 p. 52-53
 article
47 I.V. Amiodarone: What Do We Really Know About It? Raymond L. Woosley
 1998
 2 1 p. 61-63
3 p.
 article
48 I.V. Amiodarone: What Do We Really Know About It? Woosley, Raymond L.
 1998
 2 1 p. 61-63
 article
49 Overview of the National Health Care System Ali Oto
 1998
 2 1 p. 75-76
2 p.
 article
50 Overview of the National Health Care System Oto, Ali
 1998
 2 1 p. 75-76
 article
51 Practice of Electrophysiology in Taiwan Delon Wu
 1998
 2 1 p. 69-70
2 p.
 article
52 Practice of Electrophysiology in Taiwan Wu, Delon
 1998
 2 1 p. 69-70
 article
53 Private EP Practice in a Strong HMO Environment David S. Cannom
 1998
 2 1 p. 86-88
3 p.
 article
54 Private EP Practice in a Strong HMO Environment Cannom, David S.
 1998
 2 1 p. 86-88
 article
55 Quality Assurance in Pacing and Electrophysiology Mark H. Schoenfeld
 1998
 2 1 p. 94-96
3 p.
 article
56 Quality Assurance in Pacing and Electrophysiology Schoenfeld, Mark H.
 1998
 2 1 p. 94-96
 article
57 Sequential Designs in Clinical Trials David L. DeMets
 1998
 2 1 p. 57-60
4 p.
 article
58 Sequential Designs in Clinical Trials DeMets, David L.
 1998
 2 1 p. 57-60
 article
59 Spaf III Trial: Of Risk Stratification and Minimal Effective Warfarin Intensity Joseph L. Blackshear
 1998
 2 1 p. 44-48
5 p.
 article
60 Spaf III Trial: Of Risk Stratification and Minimal Effective Warfarin Intensity Blackshear, Joseph L.
 1998
 2 1 p. 44-48
 article
61 The ATRAMI Prospective Study: Implications for Risk Stratification after Myocardial Infarction Peter J. Schwartz
 1998
 2 1 p. 38-40
3 p.
 article
62 The ATRAMI Prospective Study: Implications for Risk Stratification after Myocardial Infarction Schwartz, Peter J.
 1998
 2 1 p. 38-40
 article
63 The Cardiac Arrest Study Hamburg (CASH) Riccardo Cappato
 1998
 2 1 p. 16-16
1 p.
 article
64 The Cardiac Arrest Study Hamburg (CASH) Cappato, Riccardo
 1998
 2 1 p. 16
 article
65 The Practice of Electrophysiology in Italy Michele Brignole
 1998
 2 1 p. 81-82
2 p.
 article
66 The Practice of Electrophysiology in Italy Brignole, Michele
 1998
 2 1 p. 81-82
 article
67 What to Expect from the 105th Congress: A View from Inside the Beltway Dan Nickelson
 1998
 2 1 p. 97-98
2 p.
 article
68 What to Expect from the 105th Congress: A View from Inside the Beltway Nickelson, Dan
 1998
 2 1 p. 97-98
 article
69 Workforce Planning in a Changing Environment: How Much is Enough? Alan Morgan
 1998
 2 1 p. 99-100
2 p.
 article
70 Workforce Planning in a Changing Environment: How Much is Enough? Morgan, Alan
 1998
 2 1 p. 99-100
 article
71 Working Toward an Efficient Electrophysiology Practice Antonio Pacifico
 1998
 2 1 p. 91-93
3 p.
 article
72 Working Toward an Efficient Electrophysiology Practice Pacifico, Antonio
 1998
 2 1 p. 91-93
 article
                             72 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands